A retrospective study to determine inappropriate use and dosing phenomena of Non-Vitamin K Antagonist Oral Anticoagulants Dosage Regimen
Latest Information Update: 23 Mar 2020
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Rivaroxaban (Primary) ; Warfarin (Primary)
- Indications Blood coagulation disorders; Stroke; Thromboembolism
- Focus Therapeutic Use
- 23 Mar 2020 New trial record
- 21 Feb 2020 Results presented at the International Stroke Conference 2020